SC Filed 2024-04-01 Event — SEC 0001193125-24-083703 →

Fairmount Funds Management LLC → Cogent Biosciences, Inc. COGT

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 41/100 · Filer 90d Win Rate: 60% · Hist. 90d Edge: +13.7%

Filer track record (10 filings): 60% 90d win rate, +13.7% 90d edge
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (8.9 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

22 filings by this filer

21 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 8.94

19,661,566 shares short · +1.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $29.39M

Point72 Asset Mgmt

Other 13D/G Filings on Cogent Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-22	SCHEDULE	Fairmount Funds Management LLC	9.90%	16,261,918	view →
2023-06-13	SC	Fairmount Funds Management LLC	—	—	view →

Other Filings by Fairmount Funds Management LLC

Filed	Form	Issuer	Stake	Shares
2026-10-15	SCHEDULE 13D	Alaunos Therapeutics, Inc.	19.99%	858,789	view →
2026-10-09	SCHEDULE 13D/A	SPYRE THERAPEUTICS, INC.	9.99%	9,354,200	view →
2026-09-11	SCHEDULE 13D	Korsana Biosciences, Inc.	19.99%	9,103,729	view →
2026-09-03	SCHEDULE 13D/A	Apogee Therapeutics, Inc.	—	0	view →
2026-07-20	SCHEDULE 13D/A	Crescent Biopharma, Inc.	—	6,593,385	view →
2026-07-01	SCHEDULE 13D/A	ORUKA THERAPEUTICS, INC. ORKA	19.50%	14,553,895	view →
2026-06-23	SCHEDULE 13D/A	SPYRE THERAPEUTICS, INC. SYRE	—	8,835,440	view →
2026-06-23	SCHEDULE 13D/A	Apogee Therapeutics, Inc. APGE	9.99%	6,713,519	view →
2026-06-09	SCHEDULE 13D/A	Jade Biosciences, Inc. JBIO	19.99%	14,069,494	view →
2026-05-13	SCHEDULE 13D/A	Viridian Therapeutics, Inc.\DE VRDN	—	17,201,800	view →
2026-01-22	SCHEDULE	Cogent Biosciences, Inc. COGT	9.90%	16,261,918	view →
2026-01-22	SCHEDULE	Apogee Therapeutics, Inc. APGE	9.99%	6,047,027	view →
2025-10-14	SCHEDULE	Apogee Therapeutics, Inc. APGE	9.99%	5,776,881	view →
2025-09-15	SCHEDULE	Dianthus Therapeutics, Inc. /DE/ DNTH	9.90%	4,052,052	view →
2025-03-10	SCHEDULE	Oruka Therapeutics, Inc. ORKA	19.99%	8,511,824	view →
2024-04-01	SC	Dianthus Therapeutics, Inc. /DE/ DNTH	—	—	view →
2024-04-01	SC	Viridian Therapeutics, Inc.\DE VRDN	—	—	view →
2024-04-01	SC	Apogee Therapeutics, Inc. APGE	—	—	view →
2023-12-11	SC	Spyre Therapeutics, Inc. SYRE	—	—	view →
2023-06-13	SC	Cogent Biosciences, Inc. COGT	—	—	view →

Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →